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a b s t r a c t
Background: In quantitative FDG-PET data analysis, normalization of the standardized uptake value (SUV)
with an internal image-derived standard improves its reproducibility. In this study, the cervical spinal
cord is proposed as an internal standard that is within the field of view of the radiotherapy planning
PET/CT-scan in head and neck cancer. The aim is to evaluate if the tumor to cervical spinal cord standard-
ized uptake ratio (SUR) can improve the reproducibility of a model to determine the metabolic tumor vol-
ume (MTV) on FDG-PET/CT in a multicenter setting.
Materials and methods: Ninety-five radiotherapy planning FDG-PET/CT-scans of patients with head and
neck cancer were analyzed using the Bland–Altman method to evaluate differences in FDG-uptake in
the cervical spinal cord and the mediastinal blood pool. Non-linear regression analysis was used to deter-
mine the optimal MTV using the gross tumor volume (GTV) as ground truth and a spatial overlap-index as
statistical validation metric. Reproducibility was evaluated using the Bland-Altman method and external
validation was performed in an independent dataset consisting of 62 patients.
Results: Bland–Altman’s analyses demonstrated equivalence of FDG-uptake in the mediastinal blood pool
and the cervical spinal cord. Reproducibility of the models improved when using SUR instead of SUV.
These results were confirmed in the validation cohort.
Conclusion: The use of the tumor to cervical spinal cord SUR instead of SUV improves the reproducibility
of a model to determine the MTV on FDG-PET/CT in a multicenter setting. This study indicates that SUR
may be preferred over SUV based approaches.
 2018 The Authors. Published by Elsevier B.V. Radiotherapy and Oncology 130 (2019) 39–45 This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
In recent years, 18F-fluorodeoxy-D-glucose positron emission
tomography/computed tomography (FDG-PET/CT) imaging has an
emerging role in staging, radiation treatment planning and treat-
ment response assessment in head and neck squamous cell carci-
noma [1].
The standardized uptake value (SUV) is the most commonly
used (semi-)quantitative parameter for analysis of oncologic
FDG-PET imaging [2]. However, many small physiological and tech-
nical factors can add up to considerable variations in SUV, up to 50%
or more [3]. As a consequence of significant variations in image
acquisition and reconstruction techniques, non-standardized
quantitative results are not interchangeable between institutions
[4]. Because of this poor reproducibility of the SUV, its usefulness
has been heavily criticized [5].
To ensure the interchangeability of quantitative data between
institutions, procedural guidelines aiming to harmonize acquisi-
tion and reconstruction of oncologic FDG-PET imaging were devel-
oped [2,6,7]. The reproducibility of quantitative data can be further
improved by normalization of SUV recoveries with an internal,
image-derived standard, also known as ‘tumor-to-background
ratio’ [8]. Commonly used internal standards are the liver and
the mediastinal blood pool [9,10]. Recently it was shown that an
image derived input function using the (aortic) blood pool, was
highly correlated with the arterial plasma time-activity input func-
tion to estimate the metabolic rate of glucose [11,12]. Additionally,
it was demonstrated that the tumor to (aortic) blood ratio, referred
to as the ‘standardized uptake ratio (SUR)’, has a higher correlation
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to the metabolic rate of glucose than SUV [13]. For this reason it
was suggested that SUR should be considered to replace SUV [13].
In radiotherapy for head and neck cancer, however, the medi-
astinal blood pool is usually not within the field of view of the
radiotherapy planning PET/CT-scan. An alternative structure
located in the head and neck area that may be used as an internal
standard is the cervical spinal cord. Literature reports that
FDG-uptake in the cervical spinal cord has both little inter-
patient variability and is stable over time [14,15].
The first objective of this study was to determine if FDG-uptake
in the cervical spinal cord and the mediastinal blood pool are
equivalent and can be used interchangeably. The second objective
was to investigate if the use of the tumor to cervical spinal cord
SUR instead of SUV can improve the reproducibility of a model to
determine the metabolic tumor volume (MTV) on FDG-PET/CT in
a multicenter cohort of patients with head and neck squamous cell
carcinoma.
Materials and methods
Patient selection
For the primary analysis, a total of 95 patients who received
definitive radiotherapy for head and neck squamous cell carcinoma
were eligible for this retrospective analysis. Inclusion criteria were
the acquisition of a radiotherapy planning FDG-PET/CT-scan on
which the arc of the aorta was within the field of view of the
PET/CT-scan. For the secondary analysis, an additional independent
cohort of 62 patients was included to validate the results of the pri-
mary analysis. In total, 157 patients were included and treated
between 2013 and 2017 in three tertiary head and neck clinics in
the Netherlands. Patient and tumor characteristics are shown in
Table 1. A flow diagram of the different steps of the analysis in this
study is provided as Supplementary data.
Supplementary data associated with this article can be found, in
the online version, at https://doi.org/10.1016/j.radonc.2018.06.
037.
This analysis was conducted according to the ethical principles
for medical research involving human subjects as stated in the
Declaration of Helsinki and in the ICH Good Clinical Practice
guidelines. This study was exempt from approval by an ethics com-
mittee and the need to obtain informed consent, because of the ret-
rospective character of this study and the processing of
anonymized data only.
Image acquisition and reconstruction
Contrast enhanced radiotherapy planning FDG-PET/CT-scans
were acquired in one session on EARL accredited state-of-the-art
integrated PET/CT-scanners (Siemens BioGraph 40 mCT or True-
Point). Patients were immobilized using a custom-made head, neck
and shoulders mask. Patients were kept fasted for at least 6 h
before 18F-FDG injection. Image acquisition was performed 60
min after 18F-FDG injection applying the European Association of
Nuclear Medicine (EANM) procedural guidelines for tumor PET
imaging v1.0 [2]. Because the EARL accreditation program com-
prises extensive image- and calibration quality control and (cross)-
calibrations between institutions, no additional calibrations were
performed in the context of this study. Technical characteristics
of PET/CT image acquisition and reconstruction are provided as
Supplementary data. Because PET and CT imaging were acquired
in one session using an immobilization mask, PET and CT were
co registered ‘as scanned’ (thus without need for further transla-
tions or rotations). PET image series were not resampled for anal-
ysis. Analyses of imaging were performed in Pinnacle3 v9.710
(Philips Medical Systems).
Delineation of internal standards
The cervical spinal cord was delineated by drawing a circular
region of interest (Ø 8 mm) in the center of the cervical spinal cord
on consecutive CT-slices, from the level of the cranial border of the
hyoid bone down to the caudal border of the inferior thyroid notch
(Fig. 1). The mediastinal blood pool was delineated by drawing a
circular region of interest (Ø 15 mm) in the center of the arc of
the aorta on 4 consecutive CT-slices. Delineation close to intravas-
cular calcifications or to the vascular wall was avoided. MeanTable 1Patient and tumor characteristics.
Characteristics Primary dataset
No. of patients
(n = 95)
Validation dataset
No. of patients
(n = 62)
Median age at diagnosis
(years)
64.0 (IQR: 58.0–68.6) 62.5 (IQR: 56.9–67.4)
Gender distribution
Males 64 (67.4%) 45 (72.6%)
Females 31 (32.6%) 17 (27.4%)
Primary tumor site
Nasopharynx 3 (3.2%) 0 (0.0%)
Oropharynx 52 (54.7%) 35 (56.5%)
Larynx 28 (29.5%) 19 (30.6%)
Hypopharynx 12 (12.6%) 8 (12.9%)
Stage
II 19 (20.0%) 12 (19.4%)
III 27 (28.4%) 21 (33.9%)
IV 49 (51.6%) 29 (46.8%)
T-classification
T1 2 (2.1%) 3 (4.8%)
T2 37 (38.9%) 22 (35.5%)
T3 32 (33.7%) 21 (33.9%)
T4 24 (25.3%) 16 (25.8%)
N-classification
N0 37 (38.9%) 33 (53.2%)
N1 16 (16.8%) 8 (12.9%)
N2a 4 (4.2%) 5 (8.1%)
N2b 24 (25.3%) 10 (16.1%)
N2c 14 (14.7%) 6 (9.7%)
Abbreviations: IQR = inter quartile range.
Fig. 1. Delineation of the cervical spinal cord. The cervical spinal cord is delineated
on the CT-scan by drawing a circular region of interest (Ø 8 mm) in the center of the
cervical spinal cord, starting from the level of the (A) cranial border of the hyoid
bone through the (B) caudal border of the inferior thyroid notch. View of the region
of interest in the sagittal plane (C). Projection of the cervical spinal cord on the FDG-
PET-scan (D). Abbreviations: FDG = 18F-fluorodeoxy-D-glucose; PET = Positron
Emission Tomography; CT = Computed Tomography.
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FDG-uptake values were used for analysis. Both regions of interest
approximated a volume of ±2 cc.
Gross tumor volume delineation
The gross tumor volumes (GTV) of the primary tumor and each
nodal metastases were manually delineated by consensus on the
radiotherapy planning CT-scans by an expert panel of three expe-
rienced radiation oncologists specialized in head and neck cancer.
CT-based delineation was performed according to current clinical
protocols using information from clinical examination and co-
registered diagnostic magnetic resonance imaging (MRI) in case
of oropharyngeal cancers. Necrotic lymph nodes with irrefutably
disturbed FDG-distribution were excluded from analysis.
Metabolic tumor volume
The threshold (percentage of maximum FDG-uptake) for the
MTV having the best spatial overlap with the manually delineated
GTV was determined for all lesions in all patients. For this purpose,
a total of 18 MTVs were created for each lesion, using thresholds
ranging from 10% to 95% of the maximum FDG-uptake with 5%
intervals. For each MTV, a contour of the overlapping region with
the manually delineated GTV was created. The volume and
Fig. 2. FDG-uptake in the mediastinal blood pool and cervical spinal cord. (A) Scatter plot showing the relationship between the SUV of the mediastinal blood pool and the
cervical spinal cord. (B) Bland–Altman’s plot showing the differences in SUV between the mediastinal blood pool and the cervical spinal cord. Abbreviations: SUV =
Standardized Uptake Value; SD = Standard Deviation; CI = Confidence Interval.
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maximum FDG-uptake of the GTV, MTVs and the overlapping
regions were exported for analysis.
The method of classification errors (CE) was used as a statistical
validation metric to evaluate spatial overlap quality of the manu-
ally delineated GTV with each of the MTVs [16]. An important
advantage of the CE method is that it does not only take volume
into account but also the spatial position and shape of the contours
due to the use of both false-positive and false-negative volumes
(Eq. (1)). The CE can range from 0 to infinite, in which a lower CE
implies better spatial overlap. The threshold used for the ‘optimal
MTV’ (having the lowest CE) was registered as the ‘optimal
threshold’.
Classifications Errors CEð Þ
¼ false positive volume þ false negative volume
volumeof gross tumor volume
ð1Þ
Statistical analysis
All analyses were performed using SPSS v22 for Windows (IBM
Corporation). Data characterized by normal distribution were
expressed as means with 95% confidence interval (95% CI). Param-
eters not normally distributed were expressed as median with the
interquartile range (IQR). In case of a normal distribution, compar-
ison of means was performed by applying the Student T-test for
paired- or unpaired data, as appropriate. Two tailed p-values
 0.05 were considered to be significant.
Evaluation of internal standards was performed in the primary
dataset. The bias (mean difference) and the ‘limits of agreement’
(95% CI of the bias) were calculated to evaluate for acceptable
agreement between the SUV in the mediastinal blood pool and cer-
vical spinal cord. To evaluate the magnitude of differences, the
absolute differences between SUVs were plotted against the aver-
age SUV of the mediastinal blood pool and the cervical spinal cord
according to the Bland–Altman method [17].
Models of the relationship between the maximum FDG-uptake
of a lesion (for both SUVmax and SURmax) and the optimal threshold
for the MTV (having the best spatial overlap with the GTV) were
acquired using non-linear least squares regression analysis based
on data of the primary dataset. An inverse model [y = a + (b/x)], a
power model [y = a  xb] and a sigmoidal model [y = ea + (b/x)] were
used to fit the data and the model having the best fit was used for
analysis. The tumor to cervical spinal cord standardized uptake
ratio (SURmax) was calculated using Eq. (2).
SURmax ¼ SUVmax of lesionSUVmean of cervical spinal cord ð2Þ
Reproducibility of the modelswas evaluated using the Bland–Alt-
man method by assessing the differences in threshold for and vol-
ume of the MTV that was predicted by the model and the
empirically determined optimal one, using SUVmax and SURmax
[17]. The validation dataset was used to re-evaluate the repro-
ducibility of the models that were developed based on the primary
dataset.
Results
Internal standards were evaluated in the primary dataset. The
mean SUV in the mediastinal blood pool was 1.26 (95% CI: 0.75–
1.77) and 1.23 (95% CI: 0.74–1.72) in the cervical spinal cord. There
were no inter-institutional differences of SUV in the mediastinal
blood pool (p > 0.37) or in the cervical spinal cord (p > 0.65). The
SUVs in both structures were strongly correlated with a Pearson
correlation coefficient of 0.90 (p < 0.001) (Fig. 2A). A Bland–Altman
plot shows the differences in SUV between the mediastinal blood
pool and the cervical spinal cord (Fig. 2B). There were no inter-
institutional differences in absolute differences of SUV between
the mediastinal blood pool and the cervical spinal cord (p > 0.14).
For both datasets, GTVs were delineated on CT by consensus
and MTVs were created in all patients. The MTV having the best
spatial overlap (i.e. having the lowest CE) with the GTV could be
determined for all lesions. Characteristics of contours are shown
in Table 2.
Based on the primary dataset, non-linear least squares regres-
sion analysis was used to create models describing the relationship
between SUVmax/SURmax and the optimal threshold for the MTV
(having the best spatial overlap with the GTV). The power model
fitted the data best. The model using SUVmax is described by Eq.
(3) (Fig. 3A) and the model using SURmax is described by Eq. (4)
(Fig. 3B).
Threshold % SUVmaxð Þ ¼ 119:83  SUVmaxð Þ0:66 ð3Þ
Threshold % SURmaxð Þ ¼ 116:93  SURmaxð Þ0:75 ð4Þ
Bland–Altman’s plots show the differences in threshold and vol-
ume of the MTVs that were predicted by the model when using
SUV versus SUR and the empirically determined optimal ones for
the primary dataset (Fig. 3) and the validation dataset (Fig. 4). In
the primary dataset, the ‘limits of agreement’ were significantly
Table 2
Delineation and isocontouring.
Characteristics Primary dataset
No. of patients (n = 95)
Validation dataset
No. of patients (n = 62)
Primary tumors
-No. of lesions 96 62
-Volume GTV* (cc) 15.4 (IQR: 7.6–28.5) 10.6 (IQR: 6.6–17.3)
-Volume PET** (cc) 12.7 (IQR: 5.7–21.4) 8.6 (IQR: 4.9–15.2)
-SURmax 6.7 (IQR: 4.6–9.0) 6.2 (IQR: 4.4–8.0)
-Threshold (%max) 30 (IQR: 20–40) 30 (IQR: 25–35)
-Optimal CE 0.35 (IQR: 0.26–0.43) 0.32 (IQR: 0.21–0.45)
Nodal metastases
-No. of lesions 133 80
-Volume GTV* (cc) 2.4 (IQR: 1.4–5.4) 2.1 (IQR: 1.0–4.8)
-Volume PET** (cc) 1.5 (IQR: 0.8–3.9) 1.3 (IQR: 0.7–3.8)
-SURmax 2.4 (IQR: 1.8–4.3) 2.5 (IQR: 1.9–3.6)
-Threshold (%max) 60 (IQR: 40–75) 60 (IQR: 40–70)
-Optimal CE 0.55 (IQR: 0.36–0.79) 0.55 (IQR: 0.40–0.75)
Abbreviations: GTV = gross tumor volume; PET = positron emission tomography; CE = classification errors; IQR = inter quartile range; CT = computed tomography; FDG =
fluorodeoxyglucose; SUR = standardized uptake ratio.
* Consensus GTV delineation on radiotherapy planning CT-scan.
** FDG-PET based isocontour having the best spatial overlap with the CT-based GTV.
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narrower when using SUR as compared to SUV and decreased from
35% to 25% (p = 0.04) for threshold (Fig. 3C, D) and from 18.8 cc to
12.6 cc for volume (p < 0.01) (Fig. 3E, F). Linear regression analysis
showed no relevant dependency between absolute differences and
average thresholds and volumes when using SUV or SUR.
In the secondary validation dataset, the ‘limit of agreement’ was
significantly narrower for threshold when using SUR instead of
SUV and decreased from 32% to 23% (p = 0.05) (Fig. 4A, B). For vol-
ume, the ‘limit of agreement’ decreased from 12.1 cc to 9.6 cc when
using SUR instead of SUV, but did not reach statistical significance
(p = 0.13) (Fig. 4C, D). Linear regression analysis showed a negative
dependency between absolute difference and average threshold
and volume when using SUV, indicating a systematic underestima-
tion of the MTV using the SUV-based model (Fig. 4A, C). No rele-
vant dependencies were observed for threshold or volume when
using SUR.
Discussion
It is well established that the reproducibility of quantitative
FDG-PET data can be improved by normalization of SUV recoveries
Fig. 3. Reproducibility of the models in the primary dataset (A + B). Non-linear regression models describing the relationship between the threshold for the optimal MTV
(having the best spatial overlap with the GTV) and SUVmax (A) and SURmax (B). (C + D) Bland–Altman’s plot showing the differences in threshold between the threshold for the
optimal MTV and the one predicted by the models using SUVmax (C) and SURmax (D) in the primary dataset. (E + F) Bland–Altman’s plot showing the differences in volume of
the MTV between the optimal MTV and the one predicted by de models using SUVmax (E) and SURmax (F) in the primary dataset. Abbreviations: MTV = Metabolic Tumor
Volume; GTV = Gross Tumor Volume; SUV = Standardized Uptake Value; SUR = Tumor to cervical spinal cord standardized uptake ratio; SD = Standard Deviation; CI =
Confidence Interval.
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with an internal, image-derived standard [13,18,19]. In the current
study, it was demonstrated that FDG-uptake within the cervical
spinal cord and the mediastinal blood pool are equivalent and
can be used interchangeably. The current study also shows that
the use of the tumor to cervical spinal cord SUR instead of SUV
improves the reproducibility of a model to determine the MTV
on FDG-PET/CT in a large multicenter cohort of patients with head
and neck squamous cell carcinoma. Furthermore, improvement of
reproducibility of the model was also shown in an independent
multicenter validation dataset when using SUR instead of SUV.
As such, the standardized methods described in this manuscript
are currently investigated prospectively in a clinical trial [20].
Commonly used internal image-derived standards such as the
liver and the mediastinal blood pool are not ideal for use in radio-
therapy for head and neck cancer because these structures are usu-
ally not within the field of view of the radiation treatment planning
PET/CT-scan [9,10]. For this reason, there is need for an alternative
structure in the head and neck area that can be used as internal
image-derived standard. Daisne et al. investigated the lateral mus-
cular massif of the neck as an internal image-derived standard for a
source-to-background (SBR) based segmentation algorithm in head
and neck squamous cell carcinoma [21,22]. However, the use of
muscle as internal image-derived standard in FDG-PET imaging is
less ideal, because muscular contraction due to patient discomfort
or anxiety can result in an increased physiological FDG-uptake in
skeletal muscles [23]. This can introduce uncontrollable variations
in FDG-uptake and can result in a poor inter-patient reproducibil-
ity of the internal standard. In contrast, FDG-uptake in the cervical
spinal cord has both little inter-patient variability, is stable over
time and is not influenced by muscular activity [14,15]. The cur-
rent analysis shows that the cervical spinal cord has equivalent
FDG-uptake as the mediastinal blood pool. As such, the cervical
spinal cord is ideal to be used as internal image-derived standard
in FDG-PET imaging of the head and neck area.
The next step in this analysis was to investigate if the use of the
tumor to cervical spinal cord SUR instead of SUV may improve the
reproducibility of quantitative FDG-PET data. This was done by cre-
ating a model to determine the MTV on FDG-PET/CT.
Unique in the development of this model is the use of ‘real life’
clinical FDG-PET/CT imaging data of patients with head and neck
squamous cell carcinoma. This has advantages over phantom-
based experiments, which use symmetrical volumes with homoge-
neous activity and a sharp demarcation from the background activ-
ity [22]. Obviously, ‘real life’ tumors can have complex shapes with
heterogeneous distribution of FDG-uptake and can have variable
background activity. For these reasons, models based on phantom
experiments may have a limited performance in ‘real life’ clinical
scenarios. Conversely, the advantage of phantom-based experi-
ments is a known ‘ground truth’. For this analysis, we chose the
CT-based delineation of the GTVs as a practical approximation of
‘ground truth’ for the development of the model. Special care
was taken to eliminate inter-observer variability. First, delineation
of the GTVs was performed by the consensus of three radiation
oncologists specialized in head and neck cancer. Second, the opti-
mal threshold for the MTV having the best spatial overlap with
the GTVs was determined using a spatial overlap-index as statisti-
cal validation metric.
A strength of the current analysis is that it was conducted in a
multi-center setting, which is quite challenging for evaluation of
quantitative FDG-PET imaging. A total of 95 radiation treatment
Fig. 4. Reproducibility of the models in the validation dataset (A + B). Bland–Altman’s plot showing the differences in threshold between the threshold for the optimal MTV
and the one predicted by the models using SUVmax (A) and SURmax (B) in the validation dataset. (C + D) Bland–Altman’s plot showing the differences in volume of the MTV
between the optimal MTV and the one predicted by de models using SUVmax (C) and SURmax (D) in the validation dataset. Abbreviations: MTV = Metabolic Tumor Volume;
SUV = Standardized Uptake Value; SUR = Tumor to cervical spinal cord standardized uptake ratio; SD = Standard Deviation; CI = Confidence Interval.
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planning FDG-PET/CT-scans from 3 tertiary head and neck
clinics were used for the primary analysis. Consequently, the
FDG-PET/CT-scans were acquired on 3 different PET/CT-scanners
and different reconstruction methods were used. It was demon-
strated that the reproducibility of the model to determine the
MTV on FDG-PET/CT can be significantly improved using the tumor
to cervical spinal cord SUR instead of SUV. Analysis of an indepen-
dent multicenter validation dataset consisting of 62 radiation
treatment planning FDG-PET/CT-scans confirms an improved
reproducibility of the model when using SUR instead of SUV for
threshold. For volume, a similar trend was observed, but did not
reach statistical significance. This can be explained by better com-
pliance with the EANM procedural guidelines regarding image
acquisition in the validation dataset, having a more accurate FDG
incubation time compared to the primary dataset (Supplementary
data). Most important is the systematic underestimation of the
MTV that was observed when using the SUV-based model in the
validation dataset while this was not the case for the SUR-based
model. This again suggests that the use of SUR is more robust than
SUV is, because it is less susceptible for small variations in image
acquisition.
The present study has limitations. To determine the SUR, delin-
eation of the cervical spinal cord must be performed. This could
potentially introduce new intra- and inter-observer variability
effects. However, this equally applies to traditional internal stan-
dards (e.g. liver or mediastinal blood pool). To minimize observer
variability, clear instructions for delineation of the cervical spinal
cord are described in this manuscript and illustrated in Fig. 1.
Another potential limitation of the current study is the lack of his-
tological confirmation of the GTVs. However, the objective of this
analysis was not to assess the absolute accuracy of the model to
determine the MTV on FDG-PET/CT, but to investigate if the use
of the tumor to cervical spinal cord SUR can improve the repro-
ducibility of the model. In literature, there are only two series on
head and neck cancer available using histological specimen as
ground truth reference [21,24]. These series show a slight overes-
timation of the extent of disease for CT-based GTV delineation
compared to the histological ground truth reference. Therefore, a
potential pitfall of accepting the CT-based GTV as ‘ground truth’
for the model in the current analysis may be a systematic overes-
timation of the extent of disease.
In conclusion, this study demonstrates that FDG-uptake in the
cervical spinal cord and the mediastinal blood pool is equivalent
and can be used interchangeably. The use of the tumor to cervical
spinal cord SUR instead of SUV improves the reproducibility of a
model to determine the MTV on FDG-PET/CT in a multicenter set-
ting. These results were confirmed in an independent multicenter
validation cohort. This study indicates that SUR may be preferred
over SUV based approaches.
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